Skip to content
Navigating a New Political Landscape: View real-time updates about the impact of and Northeastern’s response to recent political changes.
Apply
Stories

The J&J rescue mission starts with a choice

People in this story

The Atlantic, May 2021

Had Johnson & Johnson’s COVID-19 vaccine been the first to get the FDA’s green light, it might have been hailed from the get-go for what it actually is: a scientific and technological marvel. It requires just one injection to confer full immunity—a boon for needlephobes and tough-to-reach populations who can’t easily access a second dose. It’s relatively cheap and has forgiving refrigeration requirements, making it a breeze to ship and store. And clinical trials showed that it’s a knockout at guarding against hospitalization and death, and 66 percent effective at preventing moderate to severe cases of COVID-19, even amid the rise of antibody-dodging coronavirus variants. Johnson & Johnson accomplished all this in less than a year, granting the world a safe and effective vaccine crucial to hastening the pandemic’s eventual end.

That’s not how the J&J story played out.

Continue reading at The Atlantic.

More Stories

Economic uncertainty means fewer summer job openings for teens, said Indeed Hiring Lab's Allison Shrivastava.Adam Gray/Getty Images

There could be fewer summer jobs available for teenagers this year

06.11.2025
Mary Trump speaks during a panel discussion at Hay Festival on May 26, 2025, in Hay-on-Wye, Wales. Matthew Horwood/Getty Images

Mary Trump Predicts US to Face ‘Yet Another Test’ from Donald Trump

06.11.2025
US Senator Ted Cruz (R-TX) (Image: Getty)

Ted Cruz renews bid to designate the Muslim Brotherhood a terror group

06.11.25
All Stories